
NYSE:EL
This summary was created by AI, based on 1 opinions in the last 12 months.
Estee Lauder, trading under the symbol EL-N, has garnered attention from experts as a major investment opportunity, especially after a substantial rise of 68% noted on June 10, 2025. The combination of strong technical indicators alongside solid company fundamentals has led to a bullish outlook among analysts. Investors have expressed satisfaction with the stock's performance, indicating that it has fulfilled expectations in a relatively short timeframe. However, there is also a sense of caution that the stock may have approached its peak potential, prompting a more conservative perspective on future gains. Overall, while the returns have been impressive, some experts believe that it may be prudent to reassess the stock's trajectory moving forward.
It's been heavily shorted, but today's FDA approval of Pfizer gave it a boast. It's a play on cross-border travel (prominent in duty-free airports). No wonder it jumped over 1% today.
Hit fresh highs today Is up nearly 20% this year. She loves their deal with Target.